Molecular Classification of Hormone Receptor-Positive HER2-Negative Breast Cancer

Scientists established a large-scale multi-omics cohort of 579 patients with hormone receptor-positive /human epidermal growth factor receptor 2-negative (HER2−) breast cancer and identified the four molecular subtypes.